Cargando…
The molecular mechanism of METTL3 promoting the malignant progression of lung cancer
Lung cancer remains one of the major causes of cancer-related death globally. Recent studies have shown that aberrant m(6)A levels caused by METTL3 are involved in the malignant progression of various tumors, including lung cancer. The m(6)A modification, the most abundant RNA chemical modification,...
Autores principales: | Ma, Chao, Ma, Rui-Jie, Hu, Kang, Zheng, Qi-Ming, Wang, Ye-Peng, Zhang, Nan, Sun, Zhi-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944087/ https://www.ncbi.nlm.nih.gov/pubmed/35331234 http://dx.doi.org/10.1186/s12935-022-02539-5 |
Ejemplares similares
-
Roles of N6‐Methyladenosine Demethylase FTO in Malignant Tumors Progression
por: Zheng, Qing-Kang, et al.
Publicado: (2021) -
Krüppel-Like Factor 6 Splice Variant 1: An Oncogenic Transcription Factor Involved in the Progression of Multiple Malignant Tumors
por: Hu, Kang, et al.
Publicado: (2021) -
Knockdown of METTL14 suppresses the malignant progression of non-small cell lung cancer by reducing Twist expression
por: Yang, Fang, et al.
Publicado: (2021) -
METTL3/YTHDF2 m6A axis promotes the malignant progression of bladder cancer by epigenetically suppressing RRAS
por: Chen, Jie-Xun, et al.
Publicado: (2023) -
YTHDF2 facilitates UBXN1 mRNA decay by recognizing METTL3-mediated m(6)A modification to activate NF-κB and promote the malignant progression of glioma
por: Chai, Rui-Chao, et al.
Publicado: (2021)